Breaking: FDA issues full approval for Pfizer vaccine (access required)

By: IBR Staff August 23, 2021 Comments Off

The U.S. Food and Drug Administration (FDA) has issued full approval of the Pfizer-BioNTech COVID-19 vaccine as of Aug. 23 for individuals aged 16 and older. The vaccine will retain its emergency authorization for ages 12 through 15, which was granted on May 16. A third dose of the vaccine for certain immunocompromised individuals will ...

Complete access to news articles on idahobusinessreview.com is available to Idaho Business Review subscribers who are logged in. Subscribers may login at the login tab below. Others may join our audience with a subscription today.

Enter your email address/USER ID and password in the fields above to gain access to the subscriber content on this site.

Your subscription includes one set of login credentials for your exclusive use. Security features have been integrated on this site: If someone signs in with your credentials while you are logged in, the site will automatically close your ongoing login and you will lose access at that time. To inquire about group subscriptions for your organization, contact Shaun Witt.

Already a paid subscriber but not registered for online access yet? Click Here to register.

Forgot password or User ID?

Idaho Business Review IBR

Breaking: FDA issues full approval for Pfizer vaccine

About IBR Staff